Biotech RemeGen’s Telitacicept Shows Significant Promise in Phase II Trial for Primary Sjogren’s Syndrome: Findings Published in Prestigious Rheumatology Journal July 25, 2023
Biotech FDA Provides Update Regarding Storm Damage at Pfizer Facility in North Carolina July 22, 2023
Biotech Genprex Announces Closing of $7.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules July 22, 2023
Biotech Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) July 22, 2023
Biotech Invivoscribe Announces FDA Approval of the LeukoStrat CDx FLT3 Mutation Assay to Select Patients with FLT3-ITD Positive AML for Treatment with VANFLYTA July 21, 2023
Biotech GC Biopharma’s “GC FLU” obtains vaccine approval in Egypt: First-ever approval of the company’s quadrivalent flu vaccine on the African continent July 21, 2023
Biotech US FDA Grants Orphan Drug Designation of SN Bioscience’s Nano Anti-Cancer Drug ‘SNB-101’ for Small Cell Lung Cancer July 21, 2023